Voyager Therapeutics, Inc. (VYGR)
3.41
+0.03
(+0.89%)
USD |
NASDAQ |
Sep 04, 11:35
Voyager Therapeutics Price : 3.41 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 03, 2026 | 3.54 | 3.55 | 3.35 | 3.38 | 619980.0 |
| Sep 02, 2026 | 3.43 | 3.585 | 3.43 | 3.54 | 435034.0 |
| Sep 01, 2026 | 3.42 | 3.48 | 3.35 | 3.43 | 461285.0 |
| Aug 31, 2026 | 3.51 | 3.51 | 3.345 | 3.45 | 395564.0 |
| Aug 28, 2026 | 3.47 | 3.555 | 3.36 | 3.54 | 406269.0 |
| Aug 27, 2026 | 3.46 | 3.52 | 3.43 | 3.46 | 262793.0 |
| Aug 26, 2026 | 3.48 | 3.52 | 3.41 | 3.46 | 279758.0 |
| Aug 25, 2026 | 3.45 | 3.56 | 3.45 | 3.48 | 307584.0 |
| Aug 24, 2026 | 3.39 | 3.46 | 3.24 | 3.44 | 406167.0 |
| Aug 21, 2026 | 3.36 | 3.435 | 3.30 | 3.39 | 424442.0 |
| Aug 20, 2026 | 3.39 | 3.40 | 3.20 | 3.32 | 716951.0 |
| Aug 19, 2026 | 3.33 | 3.48 | 3.31 | 3.41 | 638548.0 |
| Aug 18, 2026 | 3.22 | 3.39 | 3.22 | 3.30 | 657988.0 |
| Aug 17, 2026 | 3.27 | 3.29 | 3.20 | 3.23 | 238836.0 |
| Aug 14, 2026 | 3.22 | 3.29 | 3.135 | 3.27 | 306188.0 |
| Aug 13, 2026 | 3.24 | 3.305 | 3.16 | 3.22 | 545345.0 |
| Aug 12, 2026 | 3.19 | 3.25 | 3.165 | 3.20 | 376087.0 |
| Aug 11, 2026 | 3.16 | 3.255 | 3.15 | 3.20 | 397997.0 |
| Aug 10, 2026 | 3.25 | 3.33 | 3.17 | 3.17 | 393465.0 |
| Aug 07, 2026 | 3.07 | 3.29 | 3.07 | 3.27 | 469297.0 |
| Aug 06, 2026 | 3.09 | 3.185 | 3.08 | 3.13 | 421077.0 |
| Aug 05, 2026 | 3.13 | 3.165 | 3.07 | 3.10 | 582215.0 |
| Aug 04, 2026 | 3.01 | 3.13 | 2.98 | 3.125 | 429009.0 |
| Aug 03, 2026 | 3.06 | 3.12 | 2.935 | 3.00 | 610449.0 |
| Jul 31, 2026 | 3.12 | 3.12 | 2.97 | 3.03 | 418963.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 8.09 |
| Amgen, Inc. | 438.16 |
| Anika Therapeutics, Inc. | 21.04 |
| BioCryst Pharmaceuticals, Inc. | 9.915 |
| Imunon, Inc. | 1.57 |
Price Related Metrics
| PS Ratio | 5.883 |
| Price to Book Value | 1.353 |
| Earnings Yield | -53.18% |
| Market Cap | 208.94M |